# Cannabinoids in Bipolar Affective Disorder

> **NCT00397605** · NA · WITHDRAWN · sponsor: **University of British Columbia**

## Conditions studied

- Bipolar Affective Disorder

## Interventions

- **DRUG:** Synthetic cannabinoids (1:1 ratio of THC % CBD)

## Key facts

- **NCT ID:** NCT00397605
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study was never started and no patients were ever enrolled
- **Last updated:** 2014-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397605, "Cannabinoids in Bipolar Affective Disorder". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00397605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*